Stocks · Health care · Surgical & Medical Instruments & Apparatus

CVRx, Inc.

CVRX Clue Score61

United States Fiscal year ends December CIK 0001235912 Results filed 5 Nov 2026

Add to watchlist

What the insiders did Net buying

By person

27 insiders · 134 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

GSK plc entity

10% owner

$4.95M (1)

—

+$4.95M

1,007,583

3.78%

$2.94M

+3,067%

Geoffrey B Pardo

Director

$4.95M (1)

—

+$4.95M

1,829,022

6.87%

$5.33M

—

Nea Partners 10 L P entity

10% owner

$4.50M (2)

—

+$4.50M

2,199,471

8.26%

$6.41M

+158,821%

Mudit K. Jain

Director

$4.37M (10)

—

+$4.37M

1,927,936

7.24%

$5.62M

+106.6%

New Enterprise Associates 10 L P entity

10% owner

$4.06M (1)

—

+$4.06M

2,026,083

7.60%

$5.91M

—

Kirk G. Nielsen

Director

$2.71M (17)

—

+$2.71M

3,380,685

12.69%

$9.85M

+131.3%

& Johnson Johnson

10% owner

—

$733.14K (7)

−$733.14K

7,536,436

28.29%

$21.97M

+115.6%

John M Nehra

Director

$502.65K (3)

—

+$502.65K

28,366

0.1065%

$82.68K

+5,701%

Kevin Hykes

Pres & CEO

$274.97K (2)

$61.35K (1) scheduled

+$213.62K

284,237

1.07%

$828.47K

—

Paul Verrastro

Chief Mktg & Strat Officer

—

$171.52K (7) scheduled

−$171.52K

60,551

0.2273%

$176.49K

—

Brent Binkowski

Chief Operating Officer

$76.43K (1)

$3.34K (1) scheduled

+$73.09K

56,514

0.2121%

$164.72K

—

Joseph P Slattery

Director

$71.74K (3)

—

+$71.74K

39,365

0.1478%

$114.74K

—

Robert Allen John

Chief Revenue Officer

—

$31.33K (1) scheduled

−$31.33K

86,036

0.3229%

$250.77K

—

Jared Oasheim

Chief Financial Officer

—

$13.78K (1) scheduled

−$13.78K

96,703

0.3630%

$281.86K

—

Philip B. Adamson

Chief Medical Officer

—

$9.97K (1) scheduled

−$9.97K

61,578

0.2311%

$179.48K

+3,247%

Dean Bruhn-Ding

VP of Reg. Affairs and Qa

—

—

—

54,648

0.2051%

$159.28K

+867.6%

Gregory Morrison

Chief Human Resources Officer

—

—

—

34,000

0.1276%

$99.10K

—

John Brintnall

Chief Strategy Officer and Sec

—

—

—

31,527

0.1183%

$91.89K

+227.5%

Michael D Dale

Director

—

—

—

29,005

0.1089%

$84.54K

—

Nadim Yared

Chief Executive Officer

—

—

—

26,255

0.0985%

$76.53K

—

Martha Shadan

Director

—

—

—

8,720

0.0327%

$25.42K

—

Mitch C. Hill,

Director

—

—

—

8,720

0.0327%

$25.42K

—

Kevin J. Ballinger

Director

—

—

—

8,720

0.0327%

$25.42K

—

Craig E. Palmer

SVP, U.s. Sales

—

—

—

1,229

0.0046%

$3.58K

—

Liz Galle

VP of Global Clinical Research

—

—

—

778

0.0029%

$2.27K

—

Ali Behbahani

Director

—

—

—

316

0.0012%

$921.05

—

Johnson & Johnson Innovation - JJDC, Inc. entity

10% owner

—

—

—

0

0.0000%

$0.00

−100.0%